Compare ADMA & HUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADMA | HUN |
|---|---|---|
| Founded | 2004 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.4B |
| IPO Year | 2012 | 2004 |
| Metric | ADMA | HUN |
|---|---|---|
| Price | $10.69 | $13.45 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 11 |
| Target Price | ★ $28.00 | $12.09 |
| AVG Volume (30 Days) | ★ 9.5M | 5.4M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.60 | N/A |
| Revenue | $42,219,783.00 | ★ $5,683,000,000.00 |
| Revenue This Year | $27.46 | $3.04 |
| Revenue Next Year | $22.11 | $5.31 |
| P/E Ratio | $17.49 | ★ N/A |
| Revenue Growth | ★ 43.85 | N/A |
| 52 Week Low | $7.21 | $7.30 |
| 52 Week High | $25.67 | $14.38 |
| Indicator | ADMA | HUN |
|---|---|---|
| Relative Strength Index (RSI) | 42.02 | 56.85 |
| Support Level | $7.21 | $10.41 |
| Resistance Level | $16.30 | $14.38 |
| Average True Range (ATR) | 0.61 | 0.72 |
| MACD | 0.29 | 0.11 |
| Stochastic Oscillator | 97.74 | 66.20 |
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. The product portfolio of the company comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, and others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. The company derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.